近日，海军军医大学第一附属医院泌尿外科主任王林辉教授、华中科技大学同济医学院附属同济医院泌 尿外科主任王少刚教授在接受媒体采访时表示，数十年来，内分泌治疗一直是前列腺癌的治疗基石；近 年来随着医学进步，前列腺癌诊疗模式还在不断进展，正从"单一用药"走向"联合用药"，并从"全面进 攻"进入"精准打击"模式；与此同时，随着AI技术的临床应用丰富化和专业人才培养体系的日趋完善， 亦为我国前列腺癌规范化诊疗水平的提升提供了坚实保障，我国前列腺癌患者的预后正持续改善。 "目前，我国前列腺癌患者的五年生存率逐步提升至70%以上，但与欧美发达国家95%以上的水平仍有 较大差距，公众的疾病认知与重视程度亟须提升。对于有家族史、年龄50岁以上或患有相关基础疾病的 男性，积极开展前列腺癌的早筛早诊至关重要。"王林辉表示，需要提高我国公众健康意识，树立早筛 早诊意识，并普及PSA筛查（前列腺特异性抗原筛查）等方式。"高危人群只需每年体检时抽一管血， 有助于在前列腺癌进展前及时干预，提升治疗效果和改善患者预后，减轻社会和家庭的疾病负担。" 在内分泌疗法出现前，主要采用手术切除睾丸来降低前列腺癌患者体内的雄激素水平。随着科学家们发 现 ...

Core Insights - Prostate cancer, often referred to as "retirement cancer," poses a significant health threat to older men globally, with rising incidence and mortality rates necessitating increased public awareness and standardized treatment protocols [1][2] Group 1: Awareness and Education Initiatives - The Beijing Integrative Medicine Association has launched a health education project for prostate cancer patients, aiming to enhance knowledge about the disease and treatment options through online and offline meetings [1] - During the National Cancer Week from April 15-21, a health education event was held by the Urology Department of Beijing Hospital, emphasizing the importance of early screening for prostate cancer [1] Group 2: Screening and Diagnosis - Early detection is crucial, as prostate cancer often progresses slowly, leading to late diagnoses when symptoms become apparent [2][3] - The prostate-specific antigen (PSA) test is an effective and affordable screening method, yet many elderly men have not undergone this test [3] - Recommendations suggest that men over 50 should have regular PSA screenings, with follow-up procedures based on PSA levels [3][4] Group 3: Treatment Approaches - The survival rate for prostate cancer patients is closely linked to the cancer stage at diagnosis, with early-stage patients having a higher likelihood of being cured through radical surgery or radiation [6] - For high-risk patients without metastasis, hormonal therapy may be used to shrink tumors before curative treatments [6] - Ongoing management and follow-up are essential in the treatment of prostate cancer to assess effectiveness and prevent treatment discontinuation [6]